Pazdur’s Sudden Exit Leaves Just Three Veterans in FDA’s Senior Ranks

Nearly 90% of senior leaders who were at the FDA a year ago are no longer with the agency, a BioSpace analysis shows. None remain from the Office of the Commissioner.